Wellington Management Group LLP Clovis Oncology, Inc. Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.85 $98,608 - $267,652	93,913 Added 20.12%	560,565 $667,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $46,716 - $102,580	32,669 Added 7.53%	466,652 $942,000
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $1.17 Million - $2.07 Million	433,983 New	433,983 $1.18 Million
Q1 2020 May 14, 2020	SELL	$3.77 - $11.0 $112,391 - $327,932	-29,812 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$3.0 - $16.43 $89,436 - $489,811	29,812 New	29,812 $311,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.